Miles Capital’s GSK GSK Stock Holding History

Miles Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,977	Closed	-$221K	–	221
2017 Q4	$221K	Hold	4,977	–	–	0.13%	153
2017 Q3	$253K	Hold	4,977	–	–	0.14%	124
2017 Q2	$268K	Hold	4,977	–	–	0.14%	127
2017 Q1	$262K	Hold	4,977	–	–	0.15%	123
2016 Q4	$240K	Buy	4,977 +934	+23%	+$46.1K	0.15%	118
2016 Q3	$218K	Buy	+4,043	New	+$222K	0.15%	112

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Miles Capital's GSK Position: Q1 2018 in Review

Miles Capital sold out of GSK (GSK) in Q1 2018, closing a stake of 4,977 shares — an estimated $221K sold.

Miles Capital first reported a position in GSK in Q3 2016 and held it in 6 quarters. The position peaked at $268K in Q2 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Miles Capital reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Miles Capital sold 4,977 GSK shares in Q1 2018, an estimated $221K.
Miles Capital first reported a position in GSK in Q3 2016 and held it in 6 quarters.
Miles Capital's GSK position peaked at $268K in Q2 2017.
779 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Miles Capital's 13F filing for Q1 2018, filed 4 May 2018.